Effect of a Cognitive Training Program on the Platelet APP Ratio in Patients with Alzheimer’s Disease

Effect of a Cognitive Training Program on the Platelet APP Ratio in Patients with Alzheimer’s Disease

In patients with Alzheimer’s disease (AD), synaptic plasticity seems to be involved in cognitive improvement induced by cognitive training. The platelet amyloid precursor protein (APP) ratio (APPr), i.e., the ratio between two APP isoforms, may be a useful peripheral biomarker to investigate synapti...

Full description

Bibliographic Details
Main Authors:	Tiziana Casoli, Cinzia Giuli, Marta Balietti, Paolo Fabbietti, Fiorenzo Conti
Format:	Article
Language:	English
Published:	MDPI AG 2020-07-01
Series:	International Journal of Molecular Sciences
Subjects:	Alzheimer’s disease platelets APP cognitive training biomarkers synaptic plasticity
Online Access:	https://www.mdpi.com/1422-0067/21/14/5110

Similar Items

LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent
by: Daniela Puzzo, et al.
Published: (2017-07-01)

Caspase Activation and Caspase-Mediated Cleavage of APP Is Associated with Amyloid β-Protein-Induced Synapse Loss in Alzheimer’s Disease
by: Goonho Park, et al.
Published: (2020-06-01)

Aη-α and Aη-β peptides impair LTP ex vivo within the low nanomolar range and impact neuronal activity in vivo
by: Maria Mensch, et al.
Published: (2021-07-01)

Platelet APP Processing: Is It a Tool to Explore the Pathophysiology of Alzheimer’s Disease? A Systematic Review
by: Manuel Glauco Carbone, et al.
Published: (2021-07-01)

The Role of APP in Structural Spine Plasticity
by: Elena Montagna, et al.
Published: (2017-05-01)

Cholinesterase inhibitors influence APP metabolism in Alzheimer disease patients
by: Martina Zimmermann, et al.
Published: (2005-06-01)

Altered GluN2B NMDA receptor function and synaptic plasticity during early pathology in the PS2APP mouse model of Alzheimer's disease
by: Jesse E. Hanson, et al.
Published: (2015-02-01)

Conséquences de la surexpression des formes solubles de l’APP dans les mécanismes de mémoire : application à la maladie d'Alzheimer
by: Fol, Romain
Published: (2016)

Commentary: APP as a Mediator of the Synapse Pathology in Alzheimer's Disease
by: An Schreurs, et al.
Published: (2018-05-01)

Effects of hippocampal aromatase overexpression on spatial learning and memory in APP/PS1 mouse model of Alzheimer's disease and related neural mechanism
by: MENG Zhaoyou, et al.
Published: (2021-05-01)

Editorial: The Physiological Functions of the APP Gene Family
by: Ulrike C. Müller, et al.
Published: (2017-10-01)

A single amino acid difference between the intracellular domains of amyloid precursor protein and amyloid-like precursor protein 2 enables induction of synaptic depression and block of long-term potentiation
by: Emilie Trillaud-Doppia, et al.
Published: (2016-07-01)

Knock-in models related to Alzheimer’s disease: synaptic transmission, plaques and the role of microglia
by: Diana P. Benitez, et al.
Published: (2021-07-01)

Dysfunctional Mitochondrial Bioenergetics and Synaptic Degeneration in Alzheimer Disease
by: Jason Tang, et al.
Published: (2019-02-01)

Differential Effect of Amyloid Beta1-40 on Short-term and Long-term Plasticity in Dentate Gyrus of a Rat Model of Alzheimer Disease
by: Javad Fahanik-Babaei, et al.
Published: (2020-07-01)

Behavioral and neural network abnormalities in human APP transgenic mice resemble those of App knock-in mice and are modulated by familial Alzheimer’s disease mutations but not by inhibition of BACE1
by: Erik C. B. Johnson, et al.
Published: (2020-09-01)

Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model
by: Ryoichi Kimura, et al.
Published: (2009-02-01)

microRNAs as Early Biomarkers of Alzheimer’s Disease: A Synaptic Perspective
by: Dolores Siedlecki-Wullich, et al.
Published: (2021-01-01)

Neuropeptide S Ameliorates Cognitive Impairment of APP/PS1 Transgenic Mice by Promoting Synaptic Plasticity and Reducing Aβ Deposition
by: Peng Zhao, et al.
Published: (2019-06-01)

Generation of the Cdk5 activator p25 is a memory mechanism that is affected in early Alzheimer’s disease
by: Karl Peter eGiese
Published: (2014-05-01)

Phosphorylation Signaling in APP Processing in Alzheimer’s Disease
by: Tao Zhang, et al.
Published: (2019-12-01)

Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition
by: Jing-Hua Zhang, et al.
Published: (2018-05-01)

Alzheimer disease and platelets: how’s that relevant
by: Catricala Silvia, et al.
Published: (2012-09-01)

Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease
by: Nadine El Tannir El Tayara, et al.
Published: (2006-04-01)

Platelet miRNA Biosignature Discriminates between Dementia with Lewy Bodies and Alzheimer’s Disease
by: Ana Gámez-Valero, et al.
Published: (2021-09-01)

Modifications and Trafficking of APP in the Pathogenesis of Alzheimer’s Disease
by: Xin Wang, et al.
Published: (2017-09-01)

Improved mitochondrial function in brain aging and Alzheimer disease - the new mechanism of action of the old metabolic enhancer piracetam
by: Kristina Leuner, et al.
Published: (2010-09-01)

Dysregulated APP expression and α-secretase processing of APP is involved in manganese-induced cognitive impairment
by: Yiping Yang, et al.
Published: (2021-09-01)

Xingnaojing ameliorates synaptic plasticity and memory deficits in an Aβ1–42 induced mouse model of Alzheimer's disease
by: Yi Liu, et al.
Published: (2020-08-01)

Platelet/lymphocyte ratio and mean platelet volume in patients with granulomatosis with polyangiitis
by: Hamit Kucuk, et al.
Published: (2019-12-01)

Fluid Candidate Biomarkers for Alzheimer’s Disease: A Precision Medicine Approach
by: Eleonora Del Prete, et al.
Published: (2020-11-01)

Normal induction but accelerated decay of LTP in APP + PS1 transgenic mice
by: I Gureviciene, et al.
Published: (2004-03-01)

Targeting Microglia-Synapse Interactions in Alzheimer’s Disease
by: Gaia Piccioni, et al.
Published: (2021-02-01)

Editorial: Alzheimer’s Disease: Original Mechanisms and Translational Impact
by: Cesare Mancuso, et al.
Published: (2020-02-01)

Suan-Zao-Ren Decoction ameliorates synaptic plasticity through inhibition of the Aβ deposition and JAK2/STAT3 signaling pathway in AD model of APP/PS1 transgenic mice
by: Qing-Hua Long, et al.
Published: (2021-01-01)

ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease
by: Florent Letronne, et al.
Published: (2016-07-01)

Opposite changes in APP processing and human Aβ levels in rats carrying either a protective or a pathogenic APP mutation
by: Marc D Tambini, et al.
Published: (2020-02-01)

Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
by: Flora H. Duits, et al.
Published: (2018-01-01)

The Emerging Role of Altered Cerebellar Synaptic Processing in Alzheimer’s Disease
by: Eriola Hoxha, et al.
Published: (2018-11-01)

Cerebrospinal Fluid of Patients With Alzheimer’s Disease Contains Increased Percentages of Synaptophysin-Bearing Microvesicles
by: Janine Utz, et al.
Published: (2021-07-01)

Cannot write session to /tmp/vufind_sessions/sess_1981ii5973qde24abg1akhjkve